Clinical Trials Logo

Filter by:
NCT ID: NCT05129124 Completed - Astigmatism Clinical Trials

Insertion Clinical Study to Evaluate the Orientation Characteristics of Multiple Kalifilcon A Daily Disposable Toric LD213001 Contact Lenses

Start date: November 30, 2021
Phase: N/A
Study type: Interventional

The objective is to evaluate the fit characteristics (primary gaze orientation, rotational recovery, and movement) of kalifilcon A daily disposable toric lenses as compared to commercially available Ultra for Astigmatism lenses.

NCT ID: NCT05129072 Completed - Contact Lens Wearer Clinical Trials

Insertion Clinical Study to Evaluate the Aberration Characteristics of Kalifilcon A Toric Lenses

Start date: August 25, 2021
Phase: N/A
Study type: Interventional

This objective of this clinical study aims to confirm whether multiple kalifilcon A daily disposable toric contact lenses are providing the intended level of spherical aberration correction when worn.

NCT ID: NCT05128929 Completed - Clinical trials for Pulmonary Hypertension

Investigation of H01 in Adults With Pulmonary Hypertension Including Interstitial Lung Disease (The SATURN Study).

SATURN
Start date: April 1, 2022
Phase: Phase 2
Study type: Interventional

This study is a prospective, randomized, double-blind, study of H01 (Hymecromone) in adults with pulmonary hypertension (PH). The primary objective of this study is to evaluate the safety and tolerability of oral H01 and the potential benefit of oral H01 on clinical measures of PH disease severity over 24 weeks. Study Hypothesis: Oral H01, at doses of 1600 mg per day, will be a safe and well-tolerated agent in adults with pulmonary hypertension over 24 weeks

NCT ID: NCT05128799 Completed - Death Clinical Trials

Effect of the 3 Wishes Program on Bereaved Families' End-of-Life Care Perceptions

Start date: October 8, 2019
Phase:
Study type: Observational

Dying in the intensive care unit (ICU) can be a source of trauma for patients and their families. The 3 Wishes Program is a palliative care initiative in which healthcare workers fulfills small wishes to provide a personalized, humanizing experience at the end of life (EOL) for dying patient and their families. The investigators' objective is to assess families' ratings of EOL care for ICU decedents who received the 3WP as part of their EOL care versus usual care.

NCT ID: NCT05128578 Completed - Cirrhosis, Liver Clinical Trials

Improving Pain Management and Opioid Safety for Patients With Cirrhosis

Start date: March 14, 2022
Phase: N/A
Study type: Interventional

This project aims to test a behavioral intervention in patients with liver cirrhosis and chronic pain and teach self pain-management skills.

NCT ID: NCT05128227 Completed - Suicide Clinical Trials

PHARM-S.A.V.E.S: Suicide Prevention Training

Start date: April 15, 2022
Phase: N/A
Study type: Interventional

This is a pilot Randomized Controlled Trial (RCT) in which 150 pharmacy staff members will be randomized to an experimental or control group and data on suicide prevention communication and secondary outcomes will be collected over the course of the RCT.

NCT ID: NCT05128136 Completed - Hiv Clinical Trials

A Crossover Study Evaluating 3 Non-medicated Silicone IVRs

Start date: January 20, 2022
Phase: N/A
Study type: Interventional

The overall aim of this study is to assess different external diameters of intravaginal rings (IVRs) for adherence, preference, and acceptability. To assess these domains, women in male-partnered relationships will use three different size IVRs.

NCT ID: NCT05128058 Completed - Healthy Clinical Trials

A Target Occupancy Study With Ritlecitinib.

Start date: October 22, 2021
Phase: Phase 1
Study type: Interventional

This is a phase 1, open label, two-arm study to assess target occupancy and functional inhibition of JAK3 and TEC kinases by Ritlecitinib in healthy adult participants

NCT ID: NCT05127850 Completed - Prostate Cancer Clinical Trials

MENCORE-2: Audio Recordings to Improve Decision-making in Advanced Prostate Cancer

Start date: March 22, 2022
Phase: N/A
Study type: Interventional

This is a single-arm hybrid implementation trial of men with metastatic castrate-resistant prostate cancer (mCRPC) involving a patient-administered mobile app for consultation audio recordings.

NCT ID: NCT05127707 Completed - Clinical trials for Substance Use Disorders

Strategies to Reduce Addiction Stigma Among Health Professionals

Start date: November 13, 2020
Phase: N/A
Study type: Interventional

The aim of this study was to evaluate the effects of exposure to stigma reduction message frames communicated by visual campaigns and narrative vignettes among a national sample of health professionals.